Hep Grow Tablet

Hep Grow is indicated as an adjunctive therapy in chronic liver diseases such as cirrhosis and acute hepatic encephalopathy to alleviate symptoms related to hyperammonemia. The tablet is typically administered orally, with dosage and duration tailored according to the severity of the condition and clinical response. Hep Grow is generally well tolerated; however, patients should be monitored for any adverse effects, and use should be cautious in individuals with hypersensitivity to any component of the formulation.

It is essential to use Hep Grow under medical supervision, particularly in patients with severe hepatic impairment or concomitant illnesses. This medication supports liver function by enhancing ammonia metabolism, thereby contributing to improved neurological outcomes in hepatic encephalopathy.